Antiviral Treatment of Patients with Recurrent Hepatitis C After Liver Transplantation with Pegylated Interferon

被引：0
|
作者：
Sven C. Schmidt
Marcus Bahra
Sandra Bayraktar
Thomas Berg
Maximilian Schmeding
Johann Pratschke
Peter Neuhaus
Ulf Neumann
机构：
[1] Universitätsmedizin Berlin,Klinik für Allgemein
[2] Universitätsmedizin Berlin,, Viszeral
来源：
Digestive Diseases and Sciences | 2010年 / 55卷
关键词：
Recurrent hepatitis C; Antiviral treatment; Liver transplantation;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2063 / 2069
页数：6
相关论文
共 50 条
  • [41] THE SUSTAINED VIROLOGICAL RESPONSE AS MARKER OF IMMUNOLOGICAL COMPLICATIONS ASSOCIATED WITH TREATMENT COMBINED WITH PEGYLATED INTERFERON AND RIBAVIRIN FOR RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION
    Barra-Valencia, Vanessa
    Gimeno Calvo, Alberto
    Perez-Saborido, Baltasar
    Fernandez, Inmaculada
    Colina Ruizdelgado, Francisco
    Fundora Suarez, Yilliam
    Meneu Diaz, Juan Carlos
    Olivares Pizarro, Sergio Pedro
    Justo Alonso, Iago
    Abradelo de Usera, Manuel
    Jimenez Romero, Carlos
    Moreno Gonzalez, Enrique
    TRANSPLANT INTERNATIONAL, 2009, 22 : 317 - 317
  • [42] Treatment of recurrent hepatitis C after liver transplantation with pegylated interferon alfa-2B plus ribavirin. Preliminary analysis
    Ghalib, RH
    Levine, CD
    Stribling, R
    McClelland, T
    Box, TD
    Hutson, WR
    Post, AB
    Regenstein, FG
    Zubi, A
    Seu, P
    Goss, J
    GASTROENTEROLOGY, 2003, 124 (04) : A694 - A694
  • [43] Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation
    Fiel, M. I.
    Shukla, D.
    Saraf, N.
    Xu, R.
    Schiano, T. D.
    TRANSPLANT INFECTIOUS DISEASE, 2008, 10 (03) : 184 - 189
  • [44] IMPACT OF PEGYLATED INTERFERON AND RIBAVIRIN TREATMENT ON GRAFT SURVIVAL IN LIVER TRANSPLANT PATIENTS WITH RECURRENT HEPATITIS C INFECTION
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Weisner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S183 - S183
  • [45] Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection
    Veldt, B. J.
    Poterucha, J. J.
    Watt, K. D. S.
    Wiesner, R. H.
    Hay, J. E.
    Kremers, W. K.
    Rosen, C. B.
    Heimbach, J. K.
    Charlton, M. R.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2008, 8 (11) : 2426 - 2433
  • [46] Trends in treatment of recurrent hepatitis C after liver transplantation
    Forgan-Smith, K. R.
    Stuart, K. A.
    Tallis, C.
    Macdonald, G. A.
    Fawcett, J.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2013, 28 : 174 - 175
  • [47] Prevention and treatment of recurrent hepatitis C after liver transplantation
    Price J.C.
    Current Hepatitis Reports, 2013, 12 (4) : 227 - 235
  • [48] Is Early Antiviral Therapy for Recurrent Hepatitis C After Liver Transplantation Superior to Later Treatment? The Answer Is No
    Roche, Bruno
    Samuel, Didier
    LIVER TRANSPLANTATION, 2011, 17 (05) : 488 - 491
  • [49] ANTIVIRAL TREATMENT IMPROVES SURVIVAL OF PATIENTS WITH CHOLESTATIC FIBROSING HEPATITIS AFTER LIVER TRANSPLANTATION FOR HEPATITIS C
    Robacys, G.
    Cassiman, D.
    Monbaliu, D.
    Aerts, R.
    Pirenne, J.
    Nevens, F.
    JOURNAL OF HEPATOLOGY, 2009, 50 : S183 - S184
  • [50] Interferon/ribavirin therapy for recurrent hepatitis C after liver transplantation.
    El-Amin, OA
    Poterucha, JJ
    Zein, NN
    Wiesner, RH
    Kim, WR
    Charlton, MR
    HEPATOLOGY, 1999, 30 (04) : 247A - 247A
12345